A cost comparison of photodynamic therapy and metallic stents in the palliation of oesophageal cancer

Photodiagnosis and Photodynamic Therapy

Volumn 4, Issue 1, 2007, Pages 65-70

  O'Donnell, C A ^a   Gray, J ^b   Hodgson, H ^b   Macpherson, M ^b   Zammit, M ^b   Fullarton, G ^b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

Author keywords

Cost comparison; Metallic stents; Photodynamic therapy

Indexed keywords

PHOTOFRIN;

AGED; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; COST; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DATA ANALYSIS; ESOPHAGUS CANCER; FEMALE; HUMAN; INFORMATION PROCESSING; LOW LEVEL LASER THERAPY; MALE; METASTASIS; PALLIATIVE THERAPY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RETROSPECTIVE STUDY; SCORING SYSTEM; STANDARD; STENT; SURVIVAL; SYMPTOMATOLOGY; TREATMENT DURATION;

EID: 33847072998     PISSN: 15721000     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pdpdt.2006.10.005     Document Type: Article

References (15)

1. Shenfine J., McNamee P., Steen N., Bond J., and Griffin S.M. A pragmatic randomised controlled trial of the cost-effectiveness of palliative therapies for patients with inoperable oesophageal cancer. Health Technol Assess 9 5 (2005) 1-121
2. Prosst R.L., Wolfsen H.C., and Gahlen J. Photodynamic therapy for oesophageal disease: a clinical update. Endoscopy 35 12 (2003) 1059-1068
3. Heier S.K., Rothman K.A., Heier L.M., and Rosenthal W.S. Photodynamic therapy for obstructing esophageal cancer: light dosimetry and randomized comparison with Ng:YAG laser therapy. Gastroenterology 109 1 (1995) 63-72
4. Luketich J.D., Nguyen N.T., Weigal T.L., Keenan R.J., Ferson P.F., and Belani C.P. Photodynamic therapy for treatment of malignant dysphagia. Surg Laparosc Endosc Percutaneous Tech 9 3 (1999) 171-175
5. Lightdale C.J., Heier S.K., Marcon N.E., et al. Photodynamic therapy with porfirmer sodium versus thermal ablations with Nd:YAG laser for palliation of oesophageal cancer: a multicenter randomized trial. Gastrointest Endosc 42 6 (1995) 507-512
6. Hopper C., Niziol C., and Sidhu M. The Cost Effectiveness of Foscan mediated photodynamic therapy compared with extensive palliative surgery and palliative chemotherapy for patients with advanced head and neck cancer in the UK. Oral oncology 40 4 (2004) 372-382
7. O'Donnell C.A., Fullarton G., Watt E., Lennon K., Murray G.D., and Moss J.G. Randomized clinical trial comparing self-expanding metallic stents with plastic endoprostheses in the palliation of oesophageal cancer. Br J Surg 89 8 (2002) 985-992
8. Drummond M.F., O'Brien B., Stoddart G.L., and Torrance G.W. Methods for the economic evaluation of health care programmes. 2nd ed. (1997), Oxford Medical Publications, Oxford
9. Treasury H.M. Economic appraisal in central government: a technical guide for government departments (1991), HMSO, London
10. British Medical Association, Royal Pharmaceutical Society of Great Britain. British National Formulary (1999), British Medical Association, Royal Pharmaceutical Society of Great Britain, London
11. Information & Statistics Division. Scottish Health Service Costs 1997/1998 (1998), National Health Service in Scotland, Edinburgh
12. Aaronson N.K., Ahmedzai S., Bergman B., et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85 5 (1993) 365-376
13. Blazeby J.M., Alderson D., Winstone K., et al. Development of an EORTC questionnaire module to be used in quality of life assessment for patients with oesophageal cancer. Eur J Cancer 32A (1996) 1912-1917
14. Thompson S.G., and Barber J.A. How should cost data in pragmatic randomised trials be analysed?. Br Med J 320 (2000) 1197-1200
15. Zoepf T., Jakobs R., Arnold J.C., Apel D., Rosenbaum A., and Riemann J.F. Photodynamic therapy for palliation of non resectable bile duct cancer-preliminary results with a new diode laser system. Am J Gastroenterol 96 7 (2001) 2093-2097